Evidence-based management of childhood atopic eczema.
Atopic eczema often develops during infancy and can have a significant impact on patients' quality of life. However, despite this the condition is often not taken seriously by health-care professionals. Atopic eczema is also a widespread problem, affecting as many as 15-20% of children in Britain. The incidence of atopic eczema has risen over the last few decades and genetic factors are no longer thought to be the only aetiological factor - it is now postulated that environmental may also play a part in the development of the condition. Recent research highlights how a defective skin barrier can be a significant issue for atopic skin. This article looks at how atopic eczema affects the quality of life of patients and details the management techniques that are available.
Carr
Julie D
JD
Sheffield Children's Hospital, UK.
D000287:Administration, Topical; D001458:Bandages; D002648:Child; D003876:Dermatitis, Atopic / Q000178:diet therapy / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D004643:Emollients / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D011788:Quality of Life; D013256:Steroids / Q000008:administration & dosage / Q000627:therapeutic use
D004643:Emollients; D013256:Steroids